Health Care & Life Sciences » Biotechnology | Capstone Therapeutics Corp.

Capstone Therapeutics Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
6,258.00
2,164.00
1,011.00
748.00
1,275.00
1,341
Other Current Assets
233.00
555.00
247.00
81.00
98.00
97
Total Current Assets
6,491.00
2,719.00
1,258.00
829.00
1,373.00
1,438
Net Property, Plant & Equipment
3.00
-
-
-
-
-
Intangible Assets
823.00
666.00
509.00
353.00
196.00
39
Total Assets
7,317.00
3,385.00
1,767.00
1,182.00
1,569.00
1,477
Accounts Payable
88.00
-
-
-
197.00
Other Current Liabilities
12.00
282.00
261.00
304.00
2.00
Total Current Liabilities
100.00
282.00
261.00
304.00
199.00
Long-Term Debt
-
-
1,000.00
1,000.00
2,249.00
Total Liabilities
100.00
282.00
1,261.00
1,304.00
2,448.00
Common Equity (Total)
7,217.00
3,103.00
506.00
122.00
879.00
Total Shareholders' Equity
7,217.00
3,103.00
506.00
122.00
879.00
Total Equity
7,217.00
3,103.00
506.00
122.00
879.00
Liabilities & Shareholders' Equity
7,317.00
3,385.00
1,767.00
1,182.00
1,569.00

About Capstone Therapeutics

View Profile
Address
1275 West Washington Street
Tempe Arizona 85281
United States
Employees -
Website http://www.capstonethx.com
Updated 07/08/2019
Capstone Therapeutics Corp. is a biotechnology company. It develops a pipeline of novel therapeutic peptides and other molecules aimed at helping patients with under-served medical conditions. The company was founded in July 1987 and is headquartered in Tempe, AZ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.